European Journal of Hospital Pharmacy

Papers
(The median citation count of European Journal of Hospital Pharmacy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?61
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy17
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease14
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients13
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent12
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings12
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years12
Is standard induction with mirikizumab sufficient in refractory ulcerative colitis in real-world practice?12
Antithrombotic stewardship: whether to stop anticoagulation after atrial fibrillation ablation11
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study11
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations11
Impact of CYP2C19 genotyping on clopidogrel therapy adjustments in patients with stroke or TIA9
Empowering European hospital pharmacists in the face of heart failure9
Advanced therapy medicinal products9
EJHP’s impact factor moves on up8
The threatened medicines information pharmacist!8
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze7
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings7
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology7
Expanded expiry dates: a regulatory opportunity for Europe7
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report7
Optimisation of the quality of care for patients with severe asthma: ASfarMA project7
Correspondence on “Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements7
Drug–drug interactions in adjuvant and neoadjuvant breast cancer therapy7
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey7
Hypoglycaemic coma induced by a falsified semaglutide product: a case report7
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care6
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts6
The end of an era!6
177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods6
Beta-lactam allergy in patients: an antibiotic stewardship challenge6
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report6
Business continuity plans for hospital pharmacies: a Delphi consensus6
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations5
Challenges and opportunities for hospital pharmacists in the management of gene and cell therapies5
Response to: Correspondence on ‘Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake5
Thoughts on the shortage of vinflunine: could we have done more?5
EMA guidance for industry to prevent and mitigate medicine shortages5
Pharmaceutical validation of peripherally inserted central catheters: four years of implementation5
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report5
Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipi5
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review4
Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements4
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 20234
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach4
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy4
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients4
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C4
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time4
Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab4
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis4
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness4
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence4
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report4
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies4
Drug-induced acute generalised exanthematous pustulosis: insights from FAERS data on a rare but severe cutaneous adverse reaction4
Medicinal mushrooms and chemotherapy: therapeutic synergy or hidden risk?4
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology3
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report3
Drug repositioning in Alzheimer’s disease: a vascular perspective targeting the NO-cGMP pathway3
Update on the hospital pharmacist profile: from clinical practice to management3
Medication-related problems in critical care survivors: a systematic review3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing3
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients3
Capecitabine: guaranteed access in adjuvant treatment of breast cancer3
Infectious diseases and antimicrobial resistance3
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database3
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management3
Hypomagnesaemia with niraparib: the need for comprehensive adverse effect reporting in drug labelling3
Clinical trials3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports3
Organisational impact of in vivo gene therapies at two French injection centres3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 20223
The future of pharmacy is already here: can we afford not to invest? Reflections from the seventh EAHP Synergy Certification Course 2025 in Bratislava3
Fully validated HPLC-UV detection method associated with colour variation control for evaluation of the stability of 5-fluorouracil chemotherapy polyolefin infusion bags at dose banding3
Penicillin allergy that persisted after 66 years: case report3
Medication adherence interventions: where are we and where do we go?3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge3
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey3
Systematic review of independent pharmacist prescribing for the treatment of cardiometabolic factors in chronic non-communicable diseases3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients3
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review3
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-193
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series3
Pharmacological resilience in the context of geopolitical tensions: a European perspective3
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?2
Association of acamprosate versus gabapentinoids with liver disease progression and alcohol-related admissions in patients with alcohol use disorder2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia2
The secret life of the surgical pharmacy in high risk periods2
Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis2
Ceftaroline combination therapy for methicillin resistant coagulase negative Staphylococcus bacteraemia and endocarditis2
When gravimetry is debated by sponsors of clinical studies2
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review2
Study of therapeutic patient education practices in French renal transplantation centres2
Results of EAHP’s 2023 shortages survey2
Patient safety culture and medication safety in European intensive care units: a focus group study2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2
Using local clinical rules in a pharmacy service to detect risk prescriptions in older adult hospital inpatients: a proof-of-concept study2
Introduction to an online only issue2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 12
Retrospective service evaluation of clinical pharmacist involvement in a critical care COVID-19 rehabilitation clinic2
Public information on shortages in the EU/EEA: improvements made between 2018 and 20202
Fixed or weight-adjusted dose in immunotherapy?2
Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach” by Protze2
Factors associated with potential drug–drug interactions in psychiatric inpatients2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques2
Pharmacist-led patient education improves medication self-management and adherence in chronic hepatitis D virus patients: insights from the EXPLAIN project2
Comparison of adverse drug reactions of statins in China from 1989 to 20192
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration2
Defining a new term: defensive hospital pharmacy practices2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment2
Safeguarding antimicrobial medicines reserved for treating humans2
Liquid antimicrobials: a national analysis of critical shortages2
Home antibiotic therapy in elastomeric infusion pumps – past, present and future2
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins2
Digital health2
European health data space proposal launched2
Identical but lethal: managing the LASA risk of plastic potassium chloride ampoules through organisational constraints2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials2
Unit dose drug dispensing systems in hospitals: a systematic review of medication error reduction and cost-effectiveness2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation2
Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study2
Drug intoxication: a silent obstacle to organ donation2
Physical compatibility of ceftriaxone and cefepime in 0.45% sodium chloride, Ringer’s lactate solution, and Plasma-Lyte A2
Looking back and looking forward2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding2
Evaluation of resources for effective decision-making about drug manipulation2
Stability of oxycodone solutions containing S -ketamine or dexmedetomidine2
Implementation of pharmacists’ monitoring for intravenous drug compatibility2
Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support syst2
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin2
To maximise impact, hospital pharmacists need to increase visibility2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp2
Realising potential and addressing risk: a UK survey of adult hepatology pharmacy services2
Thirty congresses: What a journey!2
Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital1
Hospital pharmacy workforce1
Physicochemical stability of bevacizumab biosimilar CT-P16 (Vegzelma) concentrate for solution stored in original vials after first opening1
EAHP sets out to future-proof the hospital pharmacy workforce1
Assessment of antibiotic self-medication practice among public in the northwestern region of Pakistan1
A pilot study investigating the clinical and financial impact of a pharmacist discharge service in a hospital setting1
Feasibility study of the digital tool Max for the patient-provided medication list in the medication reconciliation process prior to hospitalisation: patient willingness and usability, time saved and 1
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews1
Maintaining the stability of furosemide tablets during enteral feeding tube delivery using PVC and non-PVC tubes, in accordance with hospital protocols1
Mobile pharmacies of the Ukrainian chain ‘Apteka 9-1-1’: access to medicines during the war in Ukraine1
Beyond the 5S methodology applied to healthcare management1
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators1
Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainment1
Addressing the at-home care needs of patients with multidrug-resistant bacteria: what should we do?1
Ciclosporin-related posterior reversible encephalopathy syndrome in a paediatric haematopoietic stem cell transplant recipient1
Hospital pharmacists’ first impressions on the revision of the General Pharmaceutical Legislation1
Transitions of care: integrating pharmacists to prevent harm worldwide1
Correspondence on ‘COVID-19 vaccine triggered autoimmune hepatitis: case report’ by Mathewet al1
Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique1
Maintaining appropriate stocks in an operating room pharmaceutical unit: risk mapping of the supply chain.1
Digitising controlled substance accountability: implementation and use of a dashboard-based monitoring system in an university hospital1
Successful desensitisation to paclitaxel with omalizumab1
Posaconazole therapeutic drug monitoring in haematologic malignancies: a persistent practice gap1
Predicting unplanned hospital revisits among community-dwelling older adults: a dynamic cohort study1
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia1
Risk of exposure of patients’ family members to lenalidomide at home1
Compatibility and physicochemical stability of ceftriaxone for injection admixed with pantoprazole sodium and ondansetron hydrochloride in different infusion solutions1
Artificial intelligence and innovation in hospital pharmacy: embracing opportunities1
Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens1
Taking care of caregivers: enhancing proper medication management for palliative care children with polypharmacy1
Extravasation of brentuximab vedotin, an antibody-drug conjugate, in a patient with anaplastic large cell lymphoma1
Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments1
Factors influencing accuracy when preparing injectable drug concentrations in appliance with clinical practice: a norepinephrine case study1
Drug shortages: A critical challenge in the era of automated intravenous compounding1
Medication reconciliation at patient admission in psychiatric setting: prioritisation tool to reduce medication errors (O-PsyConcil)1
Performance and risks of ChatGPT used in drug information: comment1
Polymyxin B-related neurotoxicity: a brief case report1
EAHP general assembly updates position paper on clinical trials1
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK1
Clopidogrel-induced thrombotic microangiopathy: a case report1
Optimising electronic health records for highly specialised hospital areas: a call for collaborative hospital pharmacist involvement1
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital1
Is peer review running out of steam?1
EAHP-EANM joint statement1
Performance evaluation of the HPLC diode array and evaporative light scattering detection for the implementation of dose-banded gemcitabine infusion bags1
Nine years’ experience of an educational programme for patients treated with oral anticoagulants in a cardiology department1
Transition to adult services: the current and potential role of the UK hospital pharmacist1
Prescribe less, ask more: the patient-centred pharmacology we need1
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions1
Enhancing depression management in older cancer patients: the pharmacist’s role1
Adverse drug reactions in paediatric age: analysis of spontaneous reports and reasons for under-reporting in a Local Health Unit in Veneto region1
Comparison of sodium zirconium cyclosilicate and sodium polystyrene sulfonate in the treatment of acute hyperkalaemia1
Is one enough?1
Correspondence on ‘Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach’ by Protze1
Stability assessment and content determination test of oral liquid forms of beclomethasone dipropionate prepared in hospital pharmacy1
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study1
Drug-related problems at the heart of cardiac surgery1
Impact of patient-centred care and population health management on diabetes and hypertension outcomes1
Response to: Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approa1
Manipulating prednisolone tablets for paediatric adjustments – dose accuracy and precision1
Capillary electrophoresis in parenteral nutrition control – validation of two analytical methods: Amino acids/glucose/glucose-1-phosphate and K/Na/Ca/Mg1
Therapeutic options carried out after hypersensitivity reactions to chemotherapy: the value of skin tests1
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness1
Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit1
Gender bias in biomedical research1
Impact of the use of a drug–drug interaction checker on pharmacist interventions involving well-known strong interactors1
Contribution of hospital pharmacists to sustainable healthcare: a systematic review1
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions1
Stability of clozapine tablets repackaged in dose administration aids using repackaging machines1
Spice-drug interactions: a case report on the use of turmeric, curry and ginger in a renal transplant patient on tacrolimus1
Qualification and impact of a video-assisted control system in a chemotherapy compounding unit1
Physicochemical stability of the nefopam in elastomeric device at 0.2 and 3.33 mg/mL1
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study1
The geriatric clinical pharmacist at the emergency department: a novel front-door transdisciplinary care model1
A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration1
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials1
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation1
Ifosfamide-induced encephalopathy and concomitant use of netupitant/palonosetron in a patient with soft tissue sarcoma: a case report1
Physicochemical stability of ready-to-administer mitomycin C solutions for intravesical instillation1
Scarce plasma, rising demand: why pharmacist-led immunoglobulin stewardship matters1
Paracetamol loading dose administration in children: a retrospective study1
Potential risk of non-arteritic anterior ischaemic optic neuropathy in semaglutide users: pharmacovigilance insights1
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients1
Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?1
Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey1
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials1
1.928995847702